Total submissions: 13
Submitter | RCV | SCV | Clinical significance | Condition | Last evaluated | Review status | Method | Comment |
---|---|---|---|---|---|---|---|---|
Genetic Services Laboratory, |
RCV000116496 | SCV000150438 | likely benign | not specified | 2013-07-23 | criteria provided, single submitter | clinical testing | |
Prevention |
RCV000116496 | SCV000308018 | benign | not specified | criteria provided, single submitter | clinical testing | ||
Illumina Laboratory Services, |
RCV000013112 | SCV000471329 | benign | Maturity-onset diabetes of the young type 11 | 2018-03-06 | criteria provided, single submitter | clinical testing | This variant was observed in the ICSL laboratory as part of a predisposition screen in an ostensibly healthy population. It had not been previously curated by ICSL or reported in the Human Gene Mutation Database (HGMD: prior to June 1st, 2018), and was therefore a candidate for classification through an automated scoring system. Utilizing variant allele frequency, disease prevalence and penetrance estimates, and inheritance mode, an automated score was calculated to assess if this variant is too frequent to cause the disease. Based on the score and internal cut-off values, a variant classified as benign is not then subjected to further curation. The score for this variant resulted in a classification of benign for this disease. |
Personalized Diabetes Medicine Program, |
RCV000445395 | SCV000537051 | benign | Monogenic diabetes | 2017-03-03 | criteria provided, single submitter | research | ACMG Criteria:BP4 (6 predictors), PP3 (4 predictors), BS1 (2.5% in African 1.6% in European in 1000g), BS2 (about equal cases and controls in type2diabetesgenetics.org), PS3 (functional studies show effect) |
Laboratory for Molecular Medicine, |
RCV000116496 | SCV000538413 | benign | not specified | 2016-03-28 | criteria provided, single submitter | clinical testing | Variant identified in a genome or exome case(s) and assessed due to predicted null impact of the variant or pathogenic assertions in the literature or databases. Disclaimer: This variant has not undergone full assessment. The following are preliminary notes: Frequency |
Gene |
RCV001521947 | SCV000582792 | benign | not provided | 2018-09-25 | criteria provided, single submitter | clinical testing | This variant is associated with the following publications: (PMID: 22696686, 20981092, 26821283, 23261300, 22995991, 25333069, 19667185, 23224494, 27884173, 31101814, 32028929) |
Invitae | RCV001521947 | SCV001731387 | benign | not provided | 2024-01-31 | criteria provided, single submitter | clinical testing | |
Ce |
RCV001521947 | SCV002586218 | benign | not provided | 2023-01-01 | criteria provided, single submitter | clinical testing | BLK: BP4, BS1, BS2 |
Fulgent Genetics, |
RCV000013112 | SCV002794593 | likely benign | Maturity-onset diabetes of the young type 11 | 2021-10-05 | criteria provided, single submitter | clinical testing | |
ARUP Laboratories, |
RCV000013112 | SCV003800468 | benign | Maturity-onset diabetes of the young type 11 | 2023-11-29 | criteria provided, single submitter | clinical testing | |
OMIM | RCV000013112 | SCV000033359 | pathogenic | Maturity-onset diabetes of the young type 11 | 2009-08-25 | no assertion criteria provided | literature only | |
Laboratory of Diagnostic Genome Analysis, |
RCV000116496 | SCV001800257 | benign | not specified | no assertion criteria provided | clinical testing | ||
Genome Diagnostics Laboratory, |
RCV000116496 | SCV001928986 | benign | not specified | no assertion criteria provided | clinical testing |